1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Dementia Capable Community Health Worker Programs in the National Aging Network is sponsored by Administration for Community Living (ACL), Administration on Aging. This funding opportunity is designed to build a person-centered workforce within area agencies on aging that improves access to dementia services and helps more people live well in their communities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funding Opportunity: Dementia Capable Community Health Worker Programs in the National Aging Network | ACL Administration for Community Living Funding Opportunity: Dementia Capable Community Health Worker Programs in the National Aging Network Funding Opportunity: Dementia Capable Community Health Worker Programs in the National Aging Network Applications due Monday, August 3, 2026, 11:59 p. m.
ET A new funding opportunity is now available from ACL’s Administration on Aging: HHS-2026-ACL-AOA-ADPI-0031, “Alzheimer's Disease Programs Initiative (ADPI) - Dementia Capable Community Health Workers (CHWs). ” The awardees will receive a total of up to $750,000 for a three-year project.
This funding opportunity is designed to build a person-centered workforce within area agencies on aging that improves access to dementia services and helps more people live well in their communities. The program will increase early detection and care linkage while expanding engagement in supportive services for people living with dementia and their caregivers.
Through these efforts, recipients will work to improve participant well-being and achieve measurable outcomes over time. Click the button below to learn more and view application information on Grants. gov. Questions about this funding opportunity should be directed to aoa.
oaa@acl. hhs. gov .
See Notice of Funding Opportunity: HHS-2026-ACL-AOA-ADPI-0031, "Alzheimer's Disease Programs Initiative (ADPI) - Dementia Capable Community Health Worker Programs," posted July 2, 2026. The Administration on Aging , part of ACL, is the principal agency of the U.S. Department of Health and Human Services designated to carry out the provisions of the Older Americans Act of 1965 (OAA), as amended (42 U.S.C. A.
§ 3001 et seq.) The OAA promotes the well-being of older adults by providing services and programs that help them live independently in their homes and communities. The Act also empowers the federal government to distribute funds to the states for supportive services for individuals age 60 and older.
Last modified on 07/13/2026
According to the current listing, eligibility includes: Area agencies on aging and other eligible entities focused on services for older adults. Confirm the full requirements in the official notice before applying.
The current listing shows up to $750,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 3, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Dementia Capable Community Health Worker Programs in the National Aging Network is funded by Administration for Community Living (ACL), Administration on Aging. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article